Safety and Efficacy of Doxorubicin, Cyclophosphamide, Bortezomib, Dexamethasone and Lenalidomide Followed by Bortezomib Consolidation as First-Line Therapy in Patients with Newly Diagnosed Multiple Myeloma

Autor:	Kristian T. Andersen, Maja Hinge, Agoston Gyula Szabo, Erik Segel, Tina Ormstrup, Paw C. Holdgaard, Niels Pallisgaard, Gitte Kerndrup, Torben Plesner
Jazyk:	angličtina
Rok vydání:	2020
Předmět:	Multiple myeloma Clinical trial Hematology First line therapy Diseases of the blood and blood-forming organs RC633-647.5
Zdroj:	Clinical Hematology International, Vol 2, Iss 1 (2020)
Druh dokumentu:	article
ISSN:	2590-0048
DOI:	10.2991/chi.d.200116.001
Databáze:	Directory of Open Access Journals
Externí odkaz:	https://doaj.org/article/d5d3cf415af84c75ad7ac6e330ab6ea0 Zobrazit plný text záznamu Full text from SpringerLink View record in DOAJ